Lab Manager | Run Your Lab Like a Business
Global Virus variant and mutating cells concept or new coronavirus b.1.1.7 variants outbreak and covid-19 viral cell mutation as an influenza background with dangerous flu strain as a medical health risk as a 3D render.
Photo provided by wildpixel

SARS-CoV-2 Serologic Testing

A sample chapter from the Clinical Microbiology Procedures Handbook, 4th Edition

by Wiley
Register for free to listen to this article
Listen with Speechify
0:00
5:00

Serologic assays for detection of antibodies against SARS?CoV?2 were developed quickly following onset of the pandemic in early 2020. These assays remain quite diverse in their format and design. Increasingly, manufacturers are developing quantitative assays to detect IgG or total binding antibodies to component(s) of the SARS?CoV?2 spike glycoprotein.

Despite the wide availability of these assays, one lingering question that remains is the clinical utility of these methods: when, how, and for what should they be used?

Download this new chapter, a part of the online clinical microbiology tool ClinMicroNow, now to learn more about SARS-CoV-2 serologic testing, courtesy of Wiley.